Coronavirus Update: Moderna In Advanced Talks With Europe On Vaccine Supplies
Plus: Panacea Exits Joint Venture
Executive Summary
The deal would include an option for expansion to 160 million doses of the mRNA-based vaccine.
You may also be interested in...
No EUA For COVID-19 Vaccines Prior To Trials Completion, Says India
The Indian regulator says it is not considering emergency use authorization for COVID-19 vaccines before completion of clinical trials, a stand validated by AstraZeneca halting trials of its vaccine candidate due to an adverse event in UK. Meanwhile, India has signed up for Phase III trials of Russia’s vaccine candidate
No EUA For COVID-19 Vaccines Prior To Trials Completion, Says India
The Indian regulator says it is not considering emergency use authorization for COVID-19 vaccines before completion of clinical trials, a stand validated by AstraZeneca halting trials of its vaccine candidate due to an adverse event in UK. Meanwhile, India has signed up for Phase III trials of Russia’s vaccine candidate
Coronavirus Update: After Trump Pressure, US FDA Issues Emergency Use Authorization For Blood Plasma Therapy
US FDA Commissioner Stephen Hahn cites 35% improvement in study, but critics are dismayed by fudging of science and political pressure.